Who owns Neurocrine Biosciences (NBIX)? Superinvestor holders
5 superinvestors of the 157 tracked here hold Neurocrine Biosciences (NBIX) in their latest 13F filing, with $1.8B between them. Jim Simons (1938–2024) gives it the most weight: 0.44% of the reported portfolio. In their latest reported quarter, Joel Greenblatt and Ray Dalio (founder) added; Jim Simons (1938–2024), Dodge & Cox team and Cliff Asness reduced.
Key facts
- Superinvestors holding it
- 5 of 157
- Biggest holder
- Dodge & Cox team, $780.8M
- Largest weight
- Jim Simons (1938–2024), 0.44%of their portfolio
- Combined value
- $1.8B
- Bought last quarter
- 2
- Sold last quarter
- 3
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Jim Simons (1938–2024)Renaissance Technologies | 0.44% | $326.3M | 2.3M | ▼ Reduced 1.5% | −35.27K | Q3 2026 |
| 2 | Dodge & Cox teamDodge & Cox | 0.42% | $780.8M | 5.5M | ▼ Reduced 1.4% | −79.86K | Q3 2026 |
| 3 | Cliff AsnessAQR Capital Management | 0.22% | $643.5M | 3.82M | ▼ Reduced 23% | −1.12M | Q2 2026 |
| 4 | Joel GreenblattGotham Asset Management | 0.15% | $62.6M | 371.57K | ▲ Added 3.2% | +11.42K | Q2 2026 |
| 5 | Ray Dalio (founder)Bridgewater Associates | 0.14% | $34.7M | 205.68K | ▲ Added 39% | +57.54K | Q2 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 2 | 7.81M | $1.1B | 0 | 2 |
| Q2 2026 | 157 | 6 | 14.39M | $2.4B | 3 | 3 |
| Q1 2026 | 157 | 5 | 16.24M | $2.1B | 4 | 1 |
| Q4 2025 | 157 | 4 | 12M | $1.7B | 2 | 2 |
| Q3 2025 | 157 | 3 | 10.75M | $1.5B | 2 | 2 |
| Q2 2025 | 157 | 4 | 11.18M | $1.4B | 3 | 2 |
| Q1 2025 | 156 | 3 | 8.28M | $915.5M | 3 | 0 |
| Q4 2024 | 156 | 6 | 10.47M | $1.4B | 5 | 1 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Dodge & Cox team | 5.5M | 5.58M | 5.46M | 5.51M | 5.56M | 5.57M | 5.53M | 3.02M |
| Jim Simons (1938–2024) | 2.3M | 2.34M | 2.42M | 2.24M | 2.42M | 2.37M | 2.5M | 2.49M |
| Cliff Asness | · | 3.82M | 4.94M | 3.27M | 2.77M | — | — | 1.9M |
| John Overdeck and David Siegel (founders) | — | 2.08M | 3.06M | 984.81K | — | — | — | — |
| Joel Greenblatt | · | 371.57K | 360.14K | — | — | — | — | — |
| Ray Dalio (founder) | · | 205.68K | — | — | — | — | — | 332.6K |
| Ken Griffin | · | — | — | — | — | 2.05M | — | 2.54M |
| Israel Englander | · | — | — | — | — | 1.19M | — | — |
| George Soros | — | — | — | — | — | — | 239.82K | 200K |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own NBIX?
In their latest 13F filings: Jim Simons (1938–2024) (0.44% of the portfolio, $326.3M), Dodge & Cox team (0.42% of the portfolio, $780.8M), Cliff Asness (0.22% of the portfolio, $643.5M), Joel Greenblatt (0.15% of the portfolio, $62.6M), Ray Dalio (founder) (0.14% of the portfolio, $34.7M).
Who bought NBIX last quarter?
Joel Greenblatt (added 3.2%), Ray Dalio (founder) (added 39%). “Last quarter” is each investor's latest reported quarter.
Who sold NBIX last quarter?
Reduced: Jim Simons (1938–2024) (1.5% fewer shares), Dodge & Cox team (1.4% fewer shares), Cliff Asness (23% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Neurocrine Biosciences (NBIX)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/NBIX/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to NBIX by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.